These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 9263740)
1. Chronic administration of propranolol improves vascular contractile responsiveness in portal hypertensive rats. Huang YT; Lin HC; Tsai JF; Hou MC; Hong CY Eur J Clin Invest; 1997 Jul; 27(7):550-5. PubMed ID: 9263740 [TBL] [Abstract][Full Text] [Related]
2. Vascular hyporeactivity persists despite increased contractility after long-term administration of isosorbide dinitrate in portal hypertensive rats. Huang YT; Lin HC; Tsai JF; Hou MC; Lee SD; Hong CY J Hepatol; 1998 Jun; 28(6):1037-44. PubMed ID: 9672181 [TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y restores non-receptor-mediated vasoconstrictive action in superior mesenteric arteries in portal hypertension. Hartl J; Dietrich P; Moleda L; Müller-Schilling M; Wiest R Liver Int; 2015 Dec; 35(12):2556-63. PubMed ID: 26010514 [TBL] [Abstract][Full Text] [Related]
4. Chronic administration of octreotide increases vascular responsiveness in rats with portal hypertension. Huang YT; Tsai JF; Liu TB; Hong CY; Yang MC; Lin HC Clin Sci (Lond); 1996 Nov; 91(5):601-6. PubMed ID: 8942399 [TBL] [Abstract][Full Text] [Related]
5. Mesenteric vasoconstriction triggers nitric oxide overproduction in the superior mesenteric artery of portal hypertensive rats. Tsai MH; Iwakiri Y; Cadelina G; Sessa WC; Groszmann RJ Gastroenterology; 2003 Nov; 125(5):1452-61. PubMed ID: 14598261 [TBL] [Abstract][Full Text] [Related]
6. Haemodynamic effects of chronic tetramethylpyrazine administration on portal hypertensive rats. Chang FC; Huang YT; Hong CY; Lin JG; Chen KJ Eur J Gastroenterol Hepatol; 1999 Sep; 11(9):1027-31. PubMed ID: 10503841 [TBL] [Abstract][Full Text] [Related]
7. Propranolol modulates the collateral vascular responsiveness to vasopressin via a G(α)-mediated pathway in portal hypertensive rats. Lee JY; Huo TI; Huang HC; Lee FY; Lin HC; Chuang CL; Chang CC; Wang SS; Lee SD Clin Sci (Lond); 2011 Dec; 121(12):545-54. PubMed ID: 21736560 [TBL] [Abstract][Full Text] [Related]
8. Effects of portal hypertension on responsiveness of rat mesenteric artery and aorta. Cawley T; Geraghty J; Osborne H; Docherty JR Br J Pharmacol; 1995 Feb; 114(4):791-6. PubMed ID: 7773539 [TBL] [Abstract][Full Text] [Related]
9. Study on the vascular reactivity and alpha 1-adrenoceptors of portal hypertensive rats. Liao JF; Yu PC; Lin HC; Lee FY; Kuo JS; Yang MC Br J Pharmacol; 1994 Feb; 111(2):439-44. PubMed ID: 7911714 [TBL] [Abstract][Full Text] [Related]
10. Effect of ivabradine, a funny current inhibitor, on portal hypertensive rats. Chang CC; Lee WS; Chuang CL; Hsin IF; Hsu SJ; Huang HC; Lee FY; Lee SD J Chin Med Assoc; 2019 Jan; 82(1):19-24. PubMed ID: 30839398 [TBL] [Abstract][Full Text] [Related]
11. Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anesthetized portal hypertensive rats. Lee FY; Wang SS; Tsai YT; Lin HJ; Lin HC; Chu CJ; Wu SL; Tai CC; Lee SD J Hepatol; 1997 Mar; 26(3):687-93. PubMed ID: 9075678 [TBL] [Abstract][Full Text] [Related]
12. Hemodynamic effects of chronic tetrandrine and propranolol administration on portal hypertensive rats. Huang YT; Liu TB; Lin HC; Yang MC; Hong CY Pharmacology; 1997 May; 54(5):225-31. PubMed ID: 9380768 [TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of eight-day octreotide and propranolol administration in portal hypertensive rats. Huang YT; Cheng YR; Lin HC; Hou MC; Lee SD; Hong CY Dig Dis Sci; 1998 Feb; 43(2):358-64. PubMed ID: 9512131 [TBL] [Abstract][Full Text] [Related]
14. Decreased vascular contractile and inositol phosphate responses in portal hypertensive rats. Huang YT; Yu PC; Lee MF; Lin HC; Hong CY; Yang MC Can J Physiol Pharmacol; 1995 Mar; 73(3):378-82. PubMed ID: 7648517 [TBL] [Abstract][Full Text] [Related]
15. Vasopressin reverses mesenteric hyperemia and vasoconstrictor hyporesponsiveness in anesthetized portal hypertensive rats. Heinemann A; Wachter CH; Fickert P; Trauner M; Stauber RE Hepatology; 1998 Sep; 28(3):646-54. PubMed ID: 9731553 [TBL] [Abstract][Full Text] [Related]
16. Anatomical differences in responsiveness to vasoconstrictors in the mesenteric veins from normal and portal hypertensive rats. Moreno L; Martínez-Cuesta MA; Piqué JM; Bosch J; Esplugues JV Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):474-80. PubMed ID: 8897451 [TBL] [Abstract][Full Text] [Related]
17. Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertension. Wiest R; Jurzik L; Moleda L; Froh M; Schnabl B; von Hörsten S; Schölmerich J; Straub RH J Hepatol; 2006 Mar; 44(3):512-9. PubMed ID: 16324766 [TBL] [Abstract][Full Text] [Related]
18. The beneficial effects of curcumin in cirrhotic rats with portal hypertension. Hsu SJ; Lee JY; Lin TY; Hsieh YH; Huang HC; Lee FY; Lin HC; Hou MC; Lee SD Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29162665 [TBL] [Abstract][Full Text] [Related]
19. Fructus aurantii reduced portal pressure in portal hypertensive rats. Huang YT; Wang GF; Chen CF; Chen CC; Hong CY; Yang MC Life Sci; 1995; 57(22):2011-20. PubMed ID: 7475952 [TBL] [Abstract][Full Text] [Related]
20. Haemodynamic effects of 8-day octreotide and prazosin administration in portal hypertensive rats. Lin HC; Wu HL; Huang YT; Hou MC; Lee SD; Hong CY Eur J Clin Invest; 1998 Aug; 28(8):622-8. PubMed ID: 9767356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]